Elevated levels of citrullinated fibrinogen in patients with cancer

Documenti analoghi

• Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients
  di: Alfonso Piciocchi, et al.
  Pubblicazione: (2024)
• Clinical Significance of Elevated Levels of Soluble‐Form Immune Checkpoint Molecules in Patients With Aggressive Adult T‐Cell Leukemia‐Lymphoma
  di: Shigeo Fuji, et al.
  Pubblicazione: (2025)
• Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients
  di: Erica Franceschini, et al.
  Pubblicazione: (2024)
• Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab
  di: Syed Naqvi, et al.
  Pubblicazione: (2024)
• Association between venous thromboembolism‐associated genetic variants, coagulation factor levels, and thrombin generation potential
  di: Jihee Han, et al.
  Pubblicazione: (2024)